HNF1A/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling. Issue 3 (30th November 2018)

• Record Type: Journal Article
• Authors: Yu, Yaqun; Liang, Shuai; Zhou, Yingqiong; Li, Shuqun; Li, Yixiong; Liao, Weijia
• Is Part Of: Journal of cellular biochemistry. Volume 120:Issue 3(2019)
• Page Start: 2816
• Page End: 2827
• Publication Date: 2018-11-30
• Subjects: cell proliferation -- hepatocyte nuclear factor 1 alpha (HNF1A) -- lncRNA‐CASC2 -- pancreatic cancer (PC) -- PTEN/Akt signaling; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.26395
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: Pancreatic cancer (PC) has a high mortality rate in all cancers worldwide. According to recent studies, long noncoding RNA‐CASC2 is involved in the development and progression of many malignant tumors; in the present study, we demonstrated that lncRNA‐CASC2 was specifically downregulated in PC tissues and cell lines, and a lower CASC2 expression in PC was related with a poorer prognosis. CASC2 suppressed PC cell proliferation. Hepatocyte nuclear factor 1 alpha (HNF1A) is a transcription factor known to regulate pancreatic differentiation and maintain the homeostasis of the endocrine pancreas. Recently, HNF1A is considered to be a possible tumor suppressor in PC. In the present study, we observed that HNF1A positively regulated CASC2 expression. Through luciferase assays, we demonstrated that CASC2 gene possessed an HNF1A‐responsive element (CASC2‐HNF1A RE); HNF1A could promote CASC2 expression through direct binding to CASC2‐HNF1A RE. Further, PTEN/Akt signaling was involved in HNF1A regulation of CASC2. Finally, we evaluated the expression level of HNF1A in PC tissues; lower HNF1A expression was correlated with shorter overall survival in patients with PC. Taken together, these findings will shed light on the role and mechanism of HNF1A/CASC2 in regulating PC cells proliferation through PTEN/Akt signaling. CASC2 may serve as a potential therapeutic target in PC in the future.